Japan, Oct. 15 -- LENTIGEN TECHNOLOGY INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR TREATING HIV/AIDS WITH IMMUNOTHERAPY.' Other related details are as follows:

Application Number: JP,2025-084971

Category (FI): C07K16/112,C07K14/725,C07K19/00,C07K14/705,C12N15/869@Z,C12N15/861@Z,C12N15/86@Z,C12N15/867@Z,C12N5/10,C12N5/0783,C07K16/00,A61P31/18,A61K40/11,A61K40/31,C07K16/10,C07K16/114,C12N15/62@Z,C12N15/12,C12N15/13

Stage: Grant (IP right granted following substantive examination.)

Filing Date: May 21, 2025

Publication Date: Sept. 2, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.